Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04323098 |
|---|---|
| Brief Title: | Study to Evaluate the Efficacy and Safety of Valoctocogene Roxaparvovec, With Prophylactic Steroids in Hemophilia A (GENEr8-3) |
| First Submitted : | March 24, 2020 |
| First Submitted that Met QC Criteria : | March 25, 2020 |
| First Posted : | March 26, 2020 |
| Results First Submitted : | January 24, 2024 |
| Results First Posted with QC Comments : | February 20, 2024 |
| Results First Submitted that Met QC Criteria : | April 2, 2024 |
| Results First Posted : | April 4, 2024 |
| Last Update Submitted that Met QC Criteria : | April 2, 2024 |
| Last Update Posted : | April 4, 2024 |